Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief Report. Spira AI, Paz-Ares L, Han JY, Shih JY, et al. J Thorac Oncol 2025;20:809-816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Spira AI, Paz-Ares L, Han JY, Shih JY, et al. Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief Report. J Thorac Oncol 2025;20:809-816.
PMID: 39864547